US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Crescent Biopharma Inc

14.91

+0.79005.59%

Post-market: 14.910.00000.00%16:46 EDT

Volume:347.12K

Turnover:5.18M

Market Cap:553.82M

PE:-2.01

High:15.28

Open:14.07

Low:14.07

Close:14.12

52wk High:27.41

52wk Low:8.72

Shares:37.14M

Float Shares:15.95M

Volume Ratio:0.75

T/O Rate:2.18%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-7.4105

EPS(LYR):-12.8150

ROE:-160.75%

ROA:-69.15%

PB:7.63

PE(LYR):-1.16

Loading ...

Overview Company News Filings

Crescent Biopharma (CBIO) Gets a Buy from Stifel Nicolaus

HC Wainwright Upgrades Crescent Biopharma to Buy From Neutral, Price Target is $36

MT Newswires Live

Crescent Biopharma Raised to Buy from Neutral by HC Wainwright & Co.

Crescent Biopharma, Inc. : H.c. Wainwright Raises to Buy from Neutral

THOMSON REUTERS

Crescent Biopharma upgraded to Buy from Neutral at H.C. Wainwright

Analysts’ Top Healthcare Picks: Novartis (NVS), Crescent Biopharma (CBIO)

Crescent Biopharma Receives FDA Clearance for Investigational New Drug Application

Crescent - Initial Clinical Data from Apollo Trial Expected in Second Half of 2027

THOMSON REUTERS

Crescent Biopharma Announces FDA Clearance of Ind Application for Cr-002, a Pd-L1-Targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors

THOMSON REUTERS

Crescent - Apollo Phase 1/2 Global Trial for Cr-002 to Initiate in Q4 2026

THOMSON REUTERS

Crescent's Tumor Treatment Validated by Akeso Trial Results, Wedbush Says

MT Newswires Live

Wedbush Remains a Buy on Crescent Biopharma (CBIO)

Crescent Biopharma Price Target Maintained with a $27.00/Share by Wedbush

Crescent Biopharma Price Target Maintained with a $27.00/Share by Wedbush

Crescent Biopharma Grants Employee Stock Options for 19,425 Shares at $14.47 Each

Crescent Biopharma Q2 EPS $(0.74) Beats $(0.79) Estimate

Benzinga Earnings

Crescent Biopharma Q2 FY26 Net Loss Widens to $24.8 Million

Crescent Biopharma - Multiple Key Clinical Data Readouts Expected Beginning in Q1 2027

THOMSON REUTERS

Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights

THOMSON REUTERS

Crescent Biopharma Grants Inducement Stock Options for 52,500 Shares at $15.83 Each

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/CBIO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBIO\",,,,,undefined,":{"symbol":"CBIO","market":"US","secType":"STK","nameCN":"Crescent Biopharma Inc","latestPrice":14.91,"timestamp":1791576000000,"preClose":14.12,"halted":0,"volume":347124,"hourTrading":{"tag":"盘后","latestPrice":14.91,"preClose":14.91,"latestTime":"16:46 EDT","volume":1080,"amount":16102.8,"timestamp":1791578776274,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.05594900849858364,"floatShares":15953500,"shares":37143940,"eps":-7.4105,"marketStatus":"Market Closed","change":0.79,"latestTime":"10-09 16:00:00 EDT","open":14.07,"high":15.28,"low":14.07,"amount":5182853.077722,"amplitude":0.085694,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.4105,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1389330000000,"exchange":"NASDAQ","adjPreClose":14.12,"postHourTrading":{"tag":"盘后","latestPrice":14.91,"preClose":14.91,"latestTime":"16:46 EDT","volume":1080,"amount":16102.8,"timestamp":1791578776274,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7503717824704037,"impliedVol":0.3273,"impliedVolPercentile":0.193},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBIO\",,,,,undefined,":{"symbol":"CBIO","floatShares":15953500,"roa":"-69.15%","roe":"-160.75%","lyrEps":-12.814991,"volumeRatio":0.7503717824704037,"shares":37143940,"dividePrice":0,"high":15.28,"amplitude":0.085694,"preClose":14.12,"low":14.07,"week52Low":8.72,"pbRate":"7.63","psRate":"46.61","week52High":27.41,"institutionHeld":0.0724,"latestPrice":14.91,"eps":-7.4105,"divideRate":0,"volume":347124,"delay":0,"ttmEps":-7.4105,"open":14.07,"prevYearClose":11.86,"prevWeekClose":14.32,"prevMonthClose":14.59,"prevQuarterClose":14.59,"fiveDayClose":14.32,"twentyDayClose":19.41,"sixtyDayClose":15.11},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-30","symbol":"CBIO","fiscalQuarterEnding":"2026/06","expectedEps":-0.78,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785384000000,"reportTimeType":"pre","actualEps":-0.74},{"market":"US","date":"2026-04-29","symbol":"CBIO","fiscalQuarterEnding":"2026/03","expectedEps":-0.85,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777435200000,"reportTimeType":"post","actualEps":-0.7},{"market":"US","date":"2026-02-26","symbol":"CBIO","fiscalQuarterEnding":"2025/12","expectedEps":-2.22,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":-4.01},{"market":"US","date":"2025-11-06","symbol":"CBIO","fiscalQuarterEnding":"2025/09","expectedEps":-1.01,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-1.27},{"market":"US","date":"2025-07-31","symbol":"CBIO","fiscalQuarterEnding":"2025/06","expectedEps":-2.69,"name":null,"time":"","type":"earning","dateTimestamp":1753934400000,"reportTimeType":"","actualEps":-4.93}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CBIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.625,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1791345600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CBIO","date":"2026-10-09","current":-2.01201,"percent":0.193902,"low":-7.394562,"twenty":-3.613515,"median":-0.979043,"eighty":-0.169318,"high":2.563796,"avg":-1.597035,"sd":2.191535,"marketCap":604350995},"quantilePoints":[{"date":"2021-10-15","current":-1.622937,"twenty":-4.254957,"median":-2.206531,"eighty":-1.215339,"marketCap":125462804},{"date":"2021-10-22","current":-1.407898,"twenty":-4.254957,"median":-2.206531,"eighty":-1.215339,"marketCap":108838982},{"date":"2021-10-29","current":-1.334866,"twenty":-4.254957,"median":-2.206531,"eighty":-1.217573,"marketCap":103193156},{"date":"2021-11-05","current":-1.253719,"twenty":-4.254957,"median":-2.206531,"eighty":-1.230021,"marketCap":96920016},{"date":"2021-11-12","current":-0.620853,"twenty":-4.254957,"median":-2.206531,"eighty":-1.236189,"marketCap":53710598},{"date":"2021-11-19","current":-0.475624,"twenty":-4.254957,"median":-2.206531,"eighty":-1.236189,"marketCap":41146716},{"date":"2021-11-26","current":-0.45384,"twenty":-4.254957,"median":-2.206531,"eighty":-1.236189,"marketCap":39262133},{"date":"2021-12-03","current":-0.395748,"twenty":-4.254957,"median":-2.206531,"eighty":-1.236189,"marketCap":34236580},{"date":"2021-12-10","current":-0.395748,"twenty":-4.246633,"median":-2.205037,"eighty":-1.233979,"marketCap":34236580},{"date":"2021-12-17","current":-0.366703,"twenty":-4.246633,"median":-2.205037,"eighty":-1.233979,"marketCap":31723804},{"date":"2021-12-23","current":-0.384856,"twenty":-4.246633,"median":-2.205037,"eighty":-1.233979,"marketCap":33294289},{"date":"2021-12-31","current":-0.331848,"twenty":-4.246633,"median":-2.205037,"eighty":-1.233979,"marketCap":28708472},{"date":"2022-01-07","current":-0.303637,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":26267937},{"date":"2022-01-14","current":-0.284866,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":24644056},{"date":"2022-01-21","current":-0.232366,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":20102212},{"date":"2022-01-28","current":-0.200125,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":17313030},{"date":"2022-02-04","current":-0.201832,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":17460656},{"date":"2022-02-11","current":-0.189306,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":16377021},{"date":"2022-02-18","current":-0.215955,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":18682493},{"date":"2022-02-25","current":-0.217371,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":18804991},{"date":"2022-03-04","current":-0.241552,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":20896878},{"date":"2022-03-11","current":-0.236287,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":20441437},{"date":"2022-03-18","current":-0.243403,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":21057067},{"date":"2022-03-25","current":-0.248813,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":21525072},{"date":"2022-04-01","current":-0.236294,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":20778002},{"date":"2022-04-08","current":-0.219111,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":19267104},{"date":"2022-04-14","current":-0.194197,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":17076301},{"date":"2022-04-22","current":-0.20762,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":18256690},{"date":"2022-04-29","current":-0.171466,"twenty":-4.23831,"median":-2.203543,"eighty":-1.225062,"marketCap":15077508},{"date":"2022-05-06","current":-0.175797,"twenty":-4.23831,"median":-2.203543,"eighty":-1.212181,"marketCap":15458380},{"date":"2022-05-13","current":-0.141671,"twenty":-4.23831,"median":-2.203543,"eighty":-1.209147,"marketCap":11338034},{"date":"2022-05-20","current":-0.149458,"twenty":-4.23831,"median":-2.203543,"eighty":-1.209147,"marketCap":11961280},{"date":"2022-05-27","current":-0.483772,"twenty":-4.23831,"median":-2.203543,"eighty":-1.209147,"marketCap":38716775},{"date":"2022-06-03","current":-0.491638,"twenty":-4.23831,"median":-2.203543,"eighty":-1.206318,"marketCap":39346316},{"date":"2022-06-10","current":-0.538836,"twenty":-4.23831,"median":-2.203543,"eighty":-1.206318,"marketCap":43123562},{"date":"2022-06-17","current":-0.570301,"twenty":-4.23831,"median":-2.203543,"eighty":-1.204728,"marketCap":45641726},{"date":"2022-06-24","current":-0.593899,"twenty":-4.246633,"median":-2.205037,"eighty":-1.203969,"marketCap":47530350},{"date":"2022-07-01","current":-0.704026,"twenty":-4.246633,"median":-2.205037,"eighty":-1.190642,"marketCap":56343924},{"date":"2022-07-08","current":-0.711892,"twenty":-4.246633,"median":-2.205037,"eighty":-1.183449,"marketCap":56973465},{"date":"2022-07-15","current":-0.688294,"twenty":-4.246633,"median":-2.205037,"eighty":-1.17379,"marketCap":55084842},{"date":"2022-07-22","current":-0.688294,"twenty":-4.246633,"median":-2.205037,"eighty":-1.166615,"marketCap":55084842},{"date":"2022-07-29","current":-0.688294,"twenty":-4.246633,"median":-2.205037,"eighty":-1.164065,"marketCap":55084842},{"date":"2022-08-05","current":-0.735491,"twenty":-4.246633,"median":-2.205037,"eighty":-1.164065,"marketCap":58862089},{"date":"2022-08-12","current":-0.755157,"twenty":-4.246633,"median":-2.205037,"eighty":-1.164065,"marketCap":60435941},{"date":"2022-08-19","current":-7.394562,"twenty":-4.319663,"median":-2.219417,"eighty":-1.173236,"marketCap":62639335},{"date":"2022-08-26","current":-6.948659,"twenty":-4.374472,"median":-2.231928,"eighty":-1.186522,"marketCap":58862089},{"date":"2022-09-02","current":-7.245928,"twenty":-4.467447,"median":-2.249855,"eighty":-1.198454,"marketCap":61380253},{"date":"2022-09-09","current":-7.245928,"twenty":-4.558156,"median":-2.284285,"eighty":-1.205949,"marketCap":61380253},{"date":"2022-09-16","current":-7.283086,"twenty":-4.607295,"median":-2.335818,"eighty":-1.223882,"marketCap":61695023},{"date":"2022-09-23","current":-1.818542,"twenty":-4.702259,"median":-2.339886,"eighty":-1.237407,"marketCap":15404869},{"date":"2022-09-30","current":-1.872794,"twenty":-4.702259,"median":-2.339886,"eighty":-1.24606,"marketCap":15864434},{"date":"2022-10-07","current":-1.9891,"twenty":-4.702259,"median":-2.339886,"eighty":-1.250381,"marketCap":16849666},{"date":"2022-10-14","current":-2.235462,"twenty":-4.702259,"median":-2.339886,"eighty":-1.264627,"marketCap":18936595},{"date":"2022-10-21","current":-2.143308,"twenty":-4.702259,"median":-2.339886,"eighty":-1.287061,"marketCap":18155964},{"date":"2022-10-28","current":-2.158172,"twenty":-4.702259,"median":-2.339886,"eighty":-1.31186,"marketCap":18281872},{"date":"2022-11-04","current":-2.07345,"twenty":-4.702259,"median":-2.339886,"eighty":-1.333243,"marketCap":17564195},{"date":"2022-11-11","current":-2.064904,"twenty":-4.702259,"median":-2.339886,"eighty":-1.341215,"marketCap":17491798},{"date":"2022-11-18","current":1.47314,"twenty":-4.702259,"median":-2.339886,"eighty":-1.340298,"marketCap":17505320},{"date":"2022-11-25","current":1.457505,"twenty":-4.702259,"median":-2.339886,"eighty":-1.333243,"marketCap":17319529},{"date":"2022-12-02","current":1.457505,"twenty":-4.702259,"median":-2.339886,"eighty":-1.31186,"marketCap":17319529},{"date":"2022-12-09","current":1.350444,"twenty":-4.702259,"median":-2.339886,"eighty":-1.287061,"marketCap":16047331},{"date":"2022-12-16","current":1.319704,"twenty":-4.702259,"median":-2.33949,"eighty":-1.264627,"marketCap":15682046},{"date":"2022-12-23","current":1.332954,"twenty":-4.702259,"median":-2.284285,"eighty":-1.246705,"marketCap":15839496},{"date":"2022-12-30","current":1.397879,"twenty":-4.702259,"median":-2.249855,"eighty":-1.238056,"marketCap":16611002},{"date":"2023-01-06","current":2.033511,"twenty":-4.702259,"median":-2.235462,"eighty":-1.228022,"marketCap":24164207},{"date":"2023-01-13","current":0.834057,"twenty":-4.702259,"median":-2.228683,"eighty":-1.205599,"marketCap":9911100},{"date":"2023-01-20","current":0.847084,"twenty":-4.603457,"median":-2.215921,"eighty":-1.195389,"marketCap":10065902},{"date":"2023-01-27","current":0.937321,"twenty":-4.472686,"median":-2.202049,"eighty":-1.178581,"marketCap":11138189},{"date":"2023-02-03","current":0.926201,"twenty":-4.288569,"median":-2.18711,"eighty":-1.155134,"marketCap":11006041},{"date":"2023-02-10","current":0.79434,"twenty":-4.214316,"median":-2.168359,"eighty":-1.126768,"marketCap":9439143},{"date":"2023-02-17","current":0.798471,"twenty":-4.189559,"median":-2.158428,"eighty":-0.733918,"marketCap":9488227},{"date":"2023-02-24","current":0.76352,"twenty":-4.166469,"median":-2.154549,"eighty":-0.722119,"marketCap":9072904},{"date":"2023-03-03","current":0.752081,"twenty":-4.104269,"median":-2.149915,"eighty":-0.702453,"marketCap":8936981},{"date":"2023-03-10","current":0.629435,"twenty":-4.033134,"median":-2.136015,"eighty":-0.69852,"marketCap":7479577},{"date":"2023-03-17","current":0.621492,"twenty":-4.001878,"median":-2.108214,"eighty":-0.69616,"marketCap":7385185},{"date":"2023-03-24","current":0.660891,"twenty":-3.965473,"median":-2.07345,"eighty":-0.690654,"marketCap":7853367},{"date":"2023-03-31","current":-0.948348,"twenty":-3.915415,"median":-2.065977,"eighty":-0.688294,"marketCap":7816283},{"date":"2023-04-06","current":-0.959343,"twenty":-3.889599,"median":-2.052815,"eighty":-0.688294,"marketCap":7906907},{"date":"2023-04-14","current":-1.006532,"twenty":-3.827716,"median":-2.025144,"eighty":-0.688294,"marketCap":8295833},{"date":"2023-04-21","current":-1.094952,"twenty":-3.800801,"median":-2.009658,"eighty":-0.688294,"marketCap":9024598},{"date":"2023-04-28","current":-1.035394,"twenty":-3.762866,"median":-1.990699,"eighty":-0.688294,"marketCap":8533720},{"date":"2023-05-05","current":-0.984999,"twenty":-3.721769,"median":-1.979984,"eighty":-0.688294,"marketCap":8118362},{"date":"2023-05-12","current":-1.034936,"twenty":-3.659217,"median":-1.959683,"eighty":-0.688294,"marketCap":8529944},{"date":"2023-05-19","current":1.307824,"twenty":-3.590813,"median":-1.953003,"eighty":-0.62356,"marketCap":8571480},{"date":"2023-05-26","current":1.269223,"twenty":-3.551824,"median":-1.941439,"eighty":-0.593899,"marketCap":8318489},{"date":"2023-06-02","current":1.225437,"twenty":-3.52457,"median":-1.933362,"eighty":-0.561113,"marketCap":8031514},{"date":"2023-06-09","current":1.293997,"twenty":-3.472925,"median":-1.931296,"eighty":-0.53097,"marketCap":8480856},{"date":"2023-06-16","current":1.429965,"twenty":-3.448626,"median":-1.923181,"eighty":-0.522991,"marketCap":9371988},{"date":"2023-06-23","current":1.832106,"twenty":-3.404905,"median":-1.909241,"eighty":-0.488682,"marketCap":12007624},{"date":"2023-06-30","current":1.947333,"twenty":-3.388492,"median":-1.894612,"eighty":-0.479372,"marketCap":12762820},{"date":"2023-07-07","current":1.958856,"twenty":-3.336284,"median":-1.890722,"eighty":-0.461086,"marketCap":12838340},{"date":"2023-07-14","current":2.017045,"twenty":-3.28054,"median":-1.87855,"eighty":-0.435864,"marketCap":13219714},{"date":"2023-07-21","current":2.369063,"twenty":-3.21113,"median":-1.860968,"eighty":-0.410271,"marketCap":15526840},{"date":"2023-07-28","current":2.082724,"twenty":-3.161463,"median":-1.848291,"eighty":-0.373238,"marketCap":13650176},{"date":"2023-08-04","current":2.074083,"twenty":-3.143393,"median":-1.84,"eighty":-0.35976,"marketCap":13593537},{"date":"2023-08-11","current":1.957703,"twenty":-3.125944,"median":-1.827398,"eighty":-0.343256,"marketCap":12830788},{"date":"2023-08-18","current":-0.381172,"twenty":-3.078872,"median":-1.818996,"eighty":-0.332284,"marketCap":18124716},{"date":"2023-08-25","current":-0.415288,"twenty":-3.029373,"median":-1.817905,"eighty":-0.332284,"marketCap":19746943},{"date":"2023-09-01","current":-0.446994,"twenty":-2.989657,"median":-1.810594,"eighty":-0.332284,"marketCap":21254547},{"date":"2023-09-08","current":-0.420639,"twenty":-2.973696,"median":-1.810594,"eighty":-0.332284,"marketCap":20001375},{"date":"2023-09-15","current":-0.445556,"twenty":-2.960128,"median":-1.795851,"eighty":-0.332284,"marketCap":21186192},{"date":"2023-09-22","current":-0.394524,"twenty":-2.933767,"median":-1.789589,"eighty":-0.332284,"marketCap":18759596},{"date":"2023-09-29","current":-0.391329,"twenty":-2.919659,"median":-1.782149,"eighty":-0.332284,"marketCap":18607697},{"date":"2023-10-06","current":-0.343411,"twenty":-2.899577,"median":-1.776987,"eighty":-0.332284,"marketCap":16329203},{"date":"2023-10-13","current":-0.327439,"twenty":-2.883682,"median":-1.764944,"eighty":-0.328321,"marketCap":15569705},{"date":"2023-10-20","current":-0.320251,"twenty":-2.87071,"median":-1.755982,"eighty":-0.319653,"marketCap":15227931},{"date":"2023-10-27","current":-0.430462,"twenty":-2.848433,"median":-1.751781,"eighty":-0.315974,"marketCap":20468466},{"date":"2025-06-17","current":-0.345681,"twenty":-2.587053,"median":-1.08579,"eighty":-0.175718,"marketCap":10192829},{"date":"2025-07-25","current":-2.530939,"twenty":-2.520186,"median":-0.984999,"eighty":-0.169604,"marketCap":180881157},{"date":"2025-08-01","current":-2.414306,"twenty":-2.512378,"median":-0.984999,"eighty":-0.169604,"marketCap":172545620},{"date":"2025-08-08","current":-2.138274,"twenty":-2.502835,"median":-0.984999,"eighty":-0.169604,"marketCap":152818182},{"date":"2025-08-15","current":-2.707833,"twenty":-2.507436,"median":-0.984999,"eighty":-0.169604,"marketCap":193523388},{"date":"2025-08-22","current":-3.939042,"twenty":-2.518451,"median":-0.984999,"eighty":-0.169604,"marketCap":281515449},{"date":"2025-08-29","current":-3.870656,"twenty":-2.533218,"median":-0.984999,"eighty":-0.169604,"marketCap":276628028},{"date":"2025-09-05","current":-3.744825,"twenty":-2.546538,"median":-0.982021,"eighty":-0.169461,"marketCap":267635173},{"date":"2025-09-12","current":-3.432984,"twenty":-2.56751,"median":-0.984999,"eighty":-0.169604,"marketCap":245348534},{"date":"2025-09-19","current":-3.539667,"twenty":-2.58242,"median":-0.984999,"eighty":-0.169604,"marketCap":252972910},{"date":"2025-09-26","current":-3.394688,"twenty":-2.593613,"median":-0.984999,"eighty":-0.169604,"marketCap":242611578},{"date":"2025-10-03","current":-3.290741,"twenty":-2.627618,"median":-0.984999,"eighty":-0.169604,"marketCap":235182698},{"date":"2025-10-10","current":-3.356392,"twenty":-2.661594,"median":-0.984999,"eighty":-0.169604,"marketCap":239874622},{"date":"2025-10-17","current":-3.378276,"twenty":-2.67655,"median":-0.984999,"eighty":-0.169604,"marketCap":241438597},{"date":"2025-10-24","current":-3.498635,"twenty":-2.689355,"median":-0.984999,"eighty":-0.169604,"marketCap":250040458},{"date":"2025-10-31","current":-3.422043,"twenty":-2.698677,"median":-0.984999,"eighty":-0.169604,"marketCap":244566546},{"date":"2025-11-07","current":-3.583434,"twenty":-2.742274,"median":-0.984999,"eighty":-0.169604,"marketCap":256100860},{"date":"2025-11-14","current":-3.5506,"twenty":-2.768258,"median":-0.984999,"eighty":-0.169604,"marketCap":253754301},{"date":"2025-11-21","current":-3.577955,"twenty":-2.801418,"median":-0.984999,"eighty":-0.169604,"marketCap":255709265},{"date":"2025-11-28","current":-4.116836,"twenty":-2.807709,"median":-0.984999,"eighty":-0.169604,"marketCap":294222051},{"date":"2025-12-05","current":-3.553336,"twenty":-2.825536,"median":-0.984999,"eighty":-0.169604,"marketCap":253949797},{"date":"2025-12-12","current":-4.187958,"twenty":-2.846705,"median":-0.984999,"eighty":-0.169604,"marketCap":299304957},{"date":"2025-12-19","current":-3.342707,"twenty":-2.846705,"median":-0.984999,"eighty":-0.169604,"marketCap":238896576},{"date":"2025-12-26","current":-3.383738,"twenty":-2.870518,"median":-0.984999,"eighty":-0.169604,"marketCap":241829022},{"date":"2026-01-02","current":-3.244231,"twenty":-2.887152,"median":-0.984999,"eighty":-0.169604,"marketCap":231858706},{"date":"2026-01-09","current":-3.000777,"twenty":-2.947456,"median":-0.984999,"eighty":-0.169604,"marketCap":214459528},{"date":"2026-01-16","current":-3.419299,"twenty":-2.997495,"median":-0.984999,"eighty":-0.169604,"marketCap":244370475},{"date":"2026-01-23","current":-3.728404,"twenty":-3.025943,"median":-0.984999,"eighty":-0.169604,"marketCap":266461565},{"date":"2026-01-30","current":-2.775103,"twenty":-3.025943,"median":-0.984999,"eighty":-0.169604,"marketCap":198331077},{"date":"2026-02-06","current":-2.574048,"twenty":-2.983248,"median":-0.984999,"eighty":-0.169604,"marketCap":183962093},{"date":"2026-02-13","current":-2.524811,"twenty":-2.910905,"median":-0.984999,"eighty":-0.169604,"marketCap":180443158},{"date":"2026-02-20","current":-3.211406,"twenty":-2.875674,"median":-0.984999,"eighty":-0.169604,"marketCap":229512750},{"date":"2026-02-27","current":-3.3769,"twenty":-2.875674,"median":-0.984999,"eighty":-0.169604,"marketCap":241340281},{"date":"2026-03-06","current":-2.444514,"twenty":-2.837274,"median":-0.984999,"eighty":-0.169604,"marketCap":376313362},{"date":"2026-03-13","current":-2.494138,"twenty":-2.807709,"median":-0.984999,"eighty":-0.169604,"marketCap":383952556},{"date":"2026-03-20","current":-2.291327,"twenty":-2.77895,"median":-0.984999,"eighty":-0.169604,"marketCap":352731501},{"date":"2026-03-27","current":-2.912704,"twenty":-2.749773,"median":-0.984999,"eighty":-0.169604,"marketCap":448387501},{"date":"2026-04-02","current":-4.168403,"twenty":-2.768258,"median":-0.984999,"eighty":-0.169604,"marketCap":641692335},{"date":"2026-04-10","current":-4.120937,"twenty":-2.768258,"median":-0.984999,"eighty":-0.169604,"marketCap":634385279},{"date":"2026-04-17","current":-4.196452,"twenty":-2.77895,"median":-0.984999,"eighty":-0.169604,"marketCap":646010141},{"date":"2026-04-24","current":-5.544926,"twenty":-2.829031,"median":-0.984999,"eighty":-0.169604,"marketCap":853596947},{"date":"2026-05-01","current":-4.828663,"twenty":-2.944974,"median":-0.984999,"eighty":-0.169604,"marketCap":743334005},{"date":"2026-05-08","current":-3.690363,"twenty":-3.025943,"median":-0.984999,"eighty":-0.169604,"marketCap":598123026},{"date":"2026-05-15","current":-4.352579,"twenty":-3.088318,"median":-0.984999,"eighty":-0.169604,"marketCap":705452880},{"date":"2026-05-22","current":-4.147558,"twenty":-3.181319,"median":-0.984999,"eighty":-0.169604,"marketCap":672223823},{"date":"2026-05-29","current":-4.401783,"twenty":-3.236025,"median":-0.982021,"eighty":-0.169461,"marketCap":713427853},{"date":"2026-06-05","current":-3.782622,"twenty":-3.282788,"median":-0.984999,"eighty":-0.169604,"marketCap":613076101},{"date":"2026-06-12","current":-3.76007,"twenty":-3.344356,"median":-0.984999,"eighty":-0.169604,"marketCap":609420905},{"date":"2026-06-18","current":-3.733418,"twenty":-3.377721,"median":-0.984999,"eighty":-0.169604,"marketCap":605101127},{"date":"2026-06-26","current":-3.483293,"twenty":-3.392498,"median":-0.982021,"eighty":-0.169461,"marketCap":564561678},{"date":"2026-07-02","current":-3.501745,"twenty":-3.405077,"median":-0.982021,"eighty":-0.169461,"marketCap":567552293},{"date":"2026-07-10","current":-3.436138,"twenty":-3.419305,"median":-0.982021,"eighty":-0.169461,"marketCap":556918995},{"date":"2026-07-17","current":-3.097855,"twenty":-3.419307,"median":-0.982021,"eighty":-0.169461,"marketCap":502091051},{"date":"2026-07-24","current":-4.342042,"twenty":-3.429702,"median":-0.982021,"eighty":-0.169461,"marketCap":703745165},{"date":"2026-07-31","current":-3.829564,"twenty":-3.446389,"median":-0.979043,"eighty":-0.169318,"marketCap":620684227},{"date":"2026-08-07","current":-4.258748,"twenty":-3.477142,"median":-0.979043,"eighty":-0.169318,"marketCap":703221448},{"date":"2026-08-14","current":-4.310589,"twenty":-3.491494,"median":-0.979043,"eighty":-0.169318,"marketCap":711781661},{"date":"2026-08-21","current":-4.206907,"twenty":-3.503795,"median":-0.979043,"eighty":-0.169318,"marketCap":694661236},{"date":"2026-08-28","current":-4.603491,"twenty":-3.542402,"median":-0.979043,"eighty":-0.169318,"marketCap":760146861},{"date":"2026-09-04","current":-5.287794,"twenty":-3.55505,"median":-0.979043,"eighty":-0.169318,"marketCap":873141664},{"date":"2026-09-11","current":-5.044141,"twenty":-3.561542,"median":-0.979043,"eighty":-0.169318,"marketCap":832908666},{"date":"2026-09-18","current":-4.346878,"twenty":-3.575219,"median":-0.979043,"eighty":-0.169318,"marketCap":717773809},{"date":"2026-09-25","current":-3.691087,"twenty":-3.586169,"median":-0.979043,"eighty":-0.169318,"marketCap":609487122},{"date":"2026-10-02","current":-3.696272,"twenty":-3.602205,"median":-0.979043,"eighty":-0.169318,"marketCap":610343144},{"date":"2026-10-09","current":-3.659983,"twenty":-3.613515,"median":-0.979043,"eighty":-0.169318,"marketCap":604350995}],"updateTime":1791660493254},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CBIO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673053419","title":"Crescent Biopharma (CBIO) Gets a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2673053419","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673053419?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:58","pubTimestamp":1791284281,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Stephen Willey maintained a Buy rating on Crescent Biopharma today and set a price target of $28.00. Willey covers the Heal...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/crescent-biopharma-cbio-gets-a-buy-from-stifel-nicolaus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/crescent-biopharma-cbio-gets-a-buy-from-stifel-nicolaus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673039058","title":"HC Wainwright Upgrades Crescent Biopharma to Buy From Neutral, Price Target is $36","url":"https://stock-news.laohu8.com/highlight/detail?id=2673039058","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673039058?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:32","pubTimestamp":1791282756,"startTime":"0","endTime":"0","summary":"Crescent Biopharma (CBIO) has an average rating of buy and mean price target of $31.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673282058","title":"Crescent Biopharma Raised to Buy from Neutral by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2673282058","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673282058?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:27","pubTimestamp":1791282420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CBIO/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673955058","title":"Crescent Biopharma, Inc. : H.c. Wainwright Raises to Buy from Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2673955058","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673955058?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:18","pubTimestamp":1791281916,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nFWN45S0M4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673058159","title":"Crescent Biopharma upgraded to Buy from Neutral at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2673058159","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673058159?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:15","pubTimestamp":1791281715,"startTime":"0","endTime":"0","summary":"H.C. Wainwright upgraded Crescent Biopharma (CBIO) to Buy from Neutral with a $36 price target The shares offer an attractive risk/reward ahead of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/crescent-biopharma-upgraded-to-buy-from-neutral-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/crescent-biopharma-upgraded-to-buy-from-neutral-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673908348","title":"Analysts’ Top Healthcare Picks: Novartis (NVS), Crescent Biopharma (CBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673908348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673908348?lang=en_us&edition=fundamental","pubTime":"2026-10-05 22:40","pubTimestamp":1791211208,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Novartis (NVS) and Crescent Biopharma (CBIO) with bu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-novartis-nvs-crescent-biopharma-cbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-novartis-nvs-crescent-biopharma-cbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0211331839.USD","BK4139","IE00BFTCPJ56.SGD","BK4585","IE00BJJMRZ35.SGD","LU0070302665.USD","CBIO","BK4581","BK4532","LU0128526141.USD","BK4137","LU0320765489.SGD","XBI","IE00B4R5TH58.HKD","LU0208291251.USD","MEDX","BK4588","IE0002141913.USD","BK4007","NVS","XLV","BK4578","LABU","IE00B2B36J28.USD","HCSG","PPH","IE00BJT1NW94.SGD","LU0029874061.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673702048","title":"Crescent Biopharma Receives FDA Clearance for Investigational New Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2673702048","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673702048?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:15","pubTimestamp":1791202500,"startTime":"0","endTime":"0","summary":"Crescent Biopharma said the Food and Drug Administration cleared its investigational new drug application for CR-002 to treat advanced solid tumors.Chief Medical Officer Ellie Im on Monday said the clearance marks an important milestone for Crescent, as it means that the company can begin its trial--known as Apollo--for the drug.\"We look forward to initiating the Apollo trial this quarter and working with global investigators to generate important clinical insights and advance our mission of bringing new treatment options to patients living with difficult-to-treat cancers,\" Im said.Crescent plans to study the treatment in patients with advanced solid tumors, including non-small cell lung cancer, head and neck squamous cell carcinoma, and various gastrointestinal and gynecological tumors.Initial clinical data from the trial is expected to be reported in the second half of 2027, the company said.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","BK4139","BK4585","CBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673870473","title":"Crescent - Initial Clinical Data from Apollo Trial Expected in Second Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2673870473","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673870473?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:30","pubTimestamp":1791199802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUAZQXKL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704781","title":"Crescent Biopharma Announces FDA Clearance of Ind Application for Cr-002, a Pd-L1-Targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704781","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704781?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:30","pubTimestamp":1791199802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUAZQXKL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673047367","title":"Crescent - Apollo Phase 1/2 Global Trial for Cr-002 to Initiate in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673047367","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673047367?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:30","pubTimestamp":1791199802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUAZQXKL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667391","title":"Crescent's Tumor Treatment Validated by Akeso Trial Results, Wedbush Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667391","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667391?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:00","pubTimestamp":1789401606,"startTime":"0","endTime":"0","summary":"Crescent Biopharma's  potential treatment for advanced solid tumors CR-001 has been validated by the results of Akeso's phase 3 trial for ivonescimab, Wedbush said in a Monday note.Interim analysis showed that ivonescimab reduced the risk of death by 27% in PD-L1-positive locally advanced or metastatic non-small cell lung cancer, compared with pembrolizumab, with an improvement in median overall survival of 8.2 months, the note said.\"We view the HARMONi-2 OS confirmation as continued, and increasingly definitive, class validation for CBIO's CR-001,\" the report said.CR-001 is currently being evaluated in a phase 1/2 trialacross multiple solid tumor types, including 1L/2L NSCLC, gastric, and gynecological cancer patients, the note said, adding that initial CR-001 data are expected in Q1 of 2027.Wedbush kept its outperform rating and a price target of $27.Price: 20.16, Change: +0.75, Percent Change: +3.86","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667669867","title":"Wedbush Remains a Buy on Crescent Biopharma (CBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667669867","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667669867?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:55","pubTimestamp":1789390537,"startTime":"0","endTime":"0","summary":"In a report released today, from Wedbush maintained a Buy rating on Crescent Biopharma, with a price target of $27.00. Currently, the analyst conse...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wedbush-remains-a-buy-on-crescent-biopharma-cbio-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wedbush-remains-a-buy-on-crescent-biopharma-cbio-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667666438","title":"Crescent Biopharma Price Target Maintained with a $27.00/Share by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2667666438","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667666438?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:48","pubTimestamp":1789390080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CBIO/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662096088","title":"Crescent Biopharma Price Target Maintained with a $27.00/Share by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2662096088","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662096088?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:31","pubTimestamp":1787837460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CBIO/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656375467","title":"Crescent Biopharma Grants Employee Stock Options for 19,425 Shares at $14.47 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2656375467","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656375467?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:35","pubTimestamp":1785756906,"startTime":"0","endTime":"0","summary":"Crescent Biopharma grants employee stock options for 19,425 shares at $14.47 eachCrescent Biopharma adopted inducement equity awards granting options for 19,425 ordinary shares to one non-executive em","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL2Nxg6N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655758872","title":"Crescent Biopharma Q2 EPS $(0.74) Beats $(0.79) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2655758872","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655758872?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:14","pubTimestamp":1785413656,"startTime":"0","endTime":"0","summary":"Crescent Biopharma (NASDAQ:CBIO) reported quarterly losses of $(0.74) per share which beat the analyst consensus estimate of $(0.79) by 6.33 percent. This is a 84.99 percent increase over losses of $(4.93) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/07/60796017/crescent-biopharma-q2-eps-0-74-beats-0-79-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655874986","title":"Crescent Biopharma Q2 FY26 Net Loss Widens to $24.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655874986","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655874986?lang=en_us&edition=fundamental","pubTime":"2026-07-30 19:49","pubTimestamp":1785412142,"startTime":"0","endTime":"0","summary":"Crescent Biopharma Q2 FY26 net loss widens to $24.8 millionCrescent Biopharma posted a GAAP net loss of USD 24.8 million for Q2 2026, or USD 0.74 per share, versus a loss of USD 21.8 million.R&D expen","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL9JQRsN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655748528","title":"Crescent Biopharma - Multiple Key Clinical Data Readouts Expected Beginning in Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2655748528","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655748528?lang=en_us&edition=fundamental","pubTime":"2026-07-30 19:35","pubTimestamp":1785411300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nPLX2J7XNV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655871285","title":"Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2655871285","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655871285?lang=en_us&edition=fundamental","pubTime":"2026-07-30 19:35","pubTimestamp":1785411300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nTUACBKHWW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653776613","title":"Crescent Biopharma Grants Inducement Stock Options for 52,500 Shares at $15.83 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2653776613","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653776613?lang=en_us&edition=fundamental","pubTime":"2026-07-24 04:44","pubTimestamp":1784839483,"startTime":"0","endTime":"0","summary":"Crescent Biopharma grants inducement stock options for 52,500 shares at $15.83 eachCrescent Biopharma set inducement equity awards for two new non-executive employees, granting options covering 52,500","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL9nt3Cv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":54,"code":"91000000","status":"200"}]}}